investor.insulet.com investor.insulet.com

investor.insulet.com

Investor Relations | Insulet Corporation

The Investor Relations website contains information about Insulet Corporation's business for stockholders, potential investors, and financial analysts.

http://investor.insulet.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.INSULET.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.4 out of 5 with 10 reviews
5 star
7
4 star
0
3 star
3
2 star
0
1 star
0

Hey there! Start your review of investor.insulet.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.2 seconds

FAVICON PREVIEW

  • investor.insulet.com

    16x16

  • investor.insulet.com

    32x32

  • investor.insulet.com

    64x64

CONTACTS AT INVESTOR.INSULET.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investor Relations | Insulet Corporation | investor.insulet.com Reviews
<META>
DESCRIPTION
The Investor Relations website contains information about Insulet Corporation's business for stockholders, potential investors, and financial analysts.
<META>
KEYWORDS
1 investor relations
2 about insulet
3 press releases
4 events and presentations
5 corporate governance
6 financial information
7 stock information
8 investor contact
9 vice president
10 dgordon@insulet com
CONTENT
Page content here
KEYWORDS ON
PAGE
investor relations,about insulet,press releases,events and presentations,corporate governance,financial information,stock information,investor contact,vice president,dgordon@insulet com,ir@insulet com,insulet corporation,price,change,day high,day low,less
SERVER
nginx
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investor Relations | Insulet Corporation | investor.insulet.com Reviews

https://investor.insulet.com

The Investor Relations website contains information about Insulet Corporation's business for stockholders, potential investors, and financial analysts.

INTERNAL PAGES

investor.insulet.com investor.insulet.com
1

Insulet Corporation - Press Releases

http://investor.insulet.com/releases.cfm

See How It Works. We’re Here For You. 4 Year Limited PDM Warranty. About Insulin Pump Therapy. Deborah R. Gordon, C.P.A. Vice President, Investor Relations and Corporate Communications. 600 Technology Park Dr. Billerica, MA 01821-4150. Insulet Reports Second Quarter 2016 Financial Results. Aug 3, 2016. Insulet Corporation to Present at Upcoming Investor Conferences. Aug 1, 2016. Insulet Launches New Educational iPad App: Toby's T1D Tale. Jul 13, 2016. Omnipod Mascot Provides Diabetes Education to Childre...

2

Insulet Corporation - Analyst Coverage

http://investor.insulet.com/analysts.cfm

See How It Works. We’re Here For You. 4 Year Limited PDM Warranty. About Insulin Pump Therapy. Deborah R. Gordon, C.P.A. Vice President, Investor Relations and Corporate Communications. 600 Technology Park Dr. Billerica, MA 01821-4150. Canaccord Genuity, Inc. Piper Jaffray and Co. Robert W. Baird and Co. William Blair and Company. Mylife™ OmniPod (Europe). Of this site to obtain the appropriate information for your country of residence.

3

Insulet Corporation - SEC Filings

http://investor.insulet.com/sec.cfm

See How It Works. We’re Here For You. 4 Year Limited PDM Warranty. About Insulin Pump Therapy. Deborah R. Gordon, C.P.A. Vice President, Investor Relations and Corporate Communications. 600 Technology Park Dr. Billerica, MA 01821-4150. Aug 4, 2016. Aug 3, 2016. Spears, michael p. Jul 29, 2016. Statement of beneficial ownership. Jul 11, 2016. Jun 30, 2016. Jun 17, 2016. Sommer, regina o. May 27, 2016. May 27, 2016. Sullivan, patrick j. May 19, 2016. Thomas, bradley a. May 16, 2016. Scannell, timothy j.

4

Insulet Corporation - Quarterly Results

http://investor.insulet.com/results.cfm

See How It Works. We’re Here For You. 4 Year Limited PDM Warranty. About Insulin Pump Therapy. Deborah R. Gordon, C.P.A. Vice President, Investor Relations and Corporate Communications. 600 Technology Park Dr. Billerica, MA 01821-4150. Insulet Reports Second Quarter 2016 Financial Results. Insulet Reports First Quarter 2016 Financial Results. Insulet Reports Fourth Quarter and Full Year 2015 Financial Results. Historical Revenue by Business Line. Insulet Reports Third Quarter 2015 Financial Results.

5

Insulet Corporation - Ownership Profile

http://investor.insulet.com/ownership-profile.cfm

See How It Works. We’re Here For You. 4 Year Limited PDM Warranty. About Insulin Pump Therapy. Deborah R. Gordon, C.P.A. Vice President, Investor Relations and Corporate Communications. 600 Technology Park Dr. Billerica, MA 01821-4150. Top Holders: Institutional Investor. Wellington Management Company, LLP. Fidelity Management and Research Company. Capital Research Global Investors. The Vanguard Group, Inc. BlackRock Institutional Trust Company, N.A. Slate Path Capital LP. Valinor Management, L.P. Arrowg...

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

rominedesign.com rominedesign.com

Portfolio > Web Development

http://www.rominedesign.com/development.html

Web Design and Development. View a selection of sites I've developed. Designed and developed this Interactive Microsite using AS3/Flash. Developed Investor Site for their IPO. Rebuilt their Corporate, Investor, and Newsroom Sites. A/S Det Østasiatiske Kompagni. Designed and developed this dual landuage site from the ground up. Developed this microsite for a special event. Designed and developed this custom built responsive site from the grownd up with a collegue. AP Møller Mærsk A/S.

UPGRADE TO PREMIUM TO VIEW 3 MORE

TOTAL LINKS TO THIS WEBSITE

4

SOCIAL ENGAGEMENT



OTHER SITES

investor.inputcapital.com investor.inputcapital.com

Input Capital Corp. - Home

August 14, 2015. Canola: Canada’s Golden Crop. Changing the way we invest in the agricultural industry. Input Capital Corp. to Release F2016 Q1 Results August 18, 2015. Input Capital Corp. Reports Strong Q1 Operations. Input Capital Corp. Announces Grant of Incentive Stock Options. Input Capital Corp. Announces Fiscal 2015 Year End Results. Input Capital Corporate Presentation July 2015 Update 2. View this Presentation (PDF 2.61 MB). Sign up to receive news. Powered By Q4 Web Systems.

investor.insight.com investor.insight.com

Insight Enterprises, Inc. - Overview

Welcome to the Insight Enterprises, Inc. Investor Relations Website. We are dedicated to providing the investment community timely, accurate financial and corporate governance information about Insight Enterprises, Inc. We hope you find our Website a valuable tool in accessing this information. Please take a moment to review our Policy on Fair Disclosure. Jul 29, 2015 at 5:00 PM ET. Insight Enterprises Second Quarter 2015 Operating Results. Aug 6, 2015. Jul 29, 2015. Jul 20, 2015. Jul 16, 2015.

investor.insmed.com investor.insmed.com

Investor Relations - Insmed

Every pharmaceutical company has the ability to develop medicines, but not all have the entrepreneurial spirit for truly innovative treatments.". Michel, Principal Scientist, Research & Development. PUBLICATIONS & PRESENTATIONS. ABOUT NTM LUNG INFECTIONS. GRANTS & GIVING. 10 Finderne Ave, Building 10. Bridgewater, NJ 08807-3365. Use Up/Down Arrow keys to increase or decrease volume. We are focused on developing and commercializing drugs that treat rare diseases. Day High: 22.98. Day Low: 21.51.

investor.instancy.com investor.instancy.com

LMS Investor Relations Information Center | Instancy

Instancy Investor Relations Information Center. Instancy is raising a $5 million Series A financing to expand its sales and marketing and continue product innovation. This Investor Relations page is your first step in investigating our offering. The company is issuing convertible participating preferred stock. Please contact our Investment Advisor, Thomas E. Vass, at 919-975-4856 with any questions about our investment process. Read the Instancy Quick Deal Overview. Click to Invest Now. Instancy's multi-...

investor.insteel.com investor.insteel.com

Insteel Industries, Inc. - Company Overview

Reinforcing is our business. Insteel Industries is the nations largest manufacturer of steel wire reinforcing products for concrete construction applications. We manufacture and market prestressed concrete strand (PC strand) and welded wire reinforcement, including engineered structural mesh (ESM), concrete pipe reinforcement and standard welded wire reinforcement. Our products are sold primarily to manufacturers of concrete products that are used in nonresidential construction. Sep 19, 2017. Sep 6, 2017.

investor.insulet.com investor.insulet.com

Investor Relations | Insulet Corporation

Skip to main navigation. SIGN UP FOR ALERTS. IR and Media Contact:. Deborah R. Gordon, C.P.A. Investor Relations and Corporate Communications. 600 Technology Park Dr. Billerica, MA 01821-4150. Stock Quote (: ). Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability. And improved quality of life. 1 Diabetes Control and Complications Trial Researc...

investor.integra-ls.com investor.integra-ls.com

Investor Relations | Integra LifeSciences

Sign up for email alerts. Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, reconstructive and general surgery . More ». SeaSpine Holdings Corporation Information Statement. Â June 9, 2015. Tax Information Regarding SeaSpine Stock Distribution. Additional SeaSpine Spin-off Information. Aug 4, 2015. Aug 3, 2015.

investor.integralife.com investor.integralife.com

INVESTOR OVERVIEW | Integra LifeSciences Holdings Corporation

Skip to main navigation. Annual Reports and Proxies. Stock Distribution (Tax Information). Annual Reports and Proxies. Stock Distribution (Tax Information). There are 45 results that match your search. You should be able to find several. Indispensable facts about motivation in the following paragraphs. If there’s at least one fact you didn’t know before, imagine the difference it migh. You should be able to find several. You should be able to find several. You should be able to find several. Indispensabl...

investor.internationalpaper.com investor.internationalpaper.com

International Paper Company - Investor Relations

We deliver long-term value for all stakeholders by establishing advantaged positions in attractive, fiber-based market segments with safe, efficient manufacturing operations near sustainable fiber sources. Analyst Coverage and FAQs. Sell-side analysts covering our company and frequently asked questions from our investor community. Read the latest news about International Paper Company. Sharing information about our performance. Stock charts, quotes and more. We're Here To Help! Interested in Our Products?

investor.intevac.com investor.intevac.com

Investor Relations | Intevac

Skip to main navigation. Mar 28, 2018. Intevac’s oDLC to Begin Shipping on Top 3 Cellphone Maker’s Flagship Smartphone. Mar 01, 2018. Intevac to Present Fan-Out Packaging Results at IMAPS Device Packaging Conference 2018. View all press releases. Mar 7, 2018 4:30 PM EST. 14th International Conference and Exhibition on Device Packaging. View all events and presentations. 12:20 AM EDT on Mar 30, 2018.

investor.intuitivesurgical.com investor.intuitivesurgical.com

Intuitive Surgical - Investors - Investor Relations Home

Research and Educational Grants. Intuitive Surgical, Inc. (NASDAQ: ISRG) is the global technology leader in robotic-assisted minimally invasive surgery (MIS). The Company's da Vinci Surgical System offers surgeons superior visualization, enhanced dexterity, greater precision and ergonomic comfort for the optimal performance of MIS. The da Vinci System enables surgeons to perform even complex procedures such as open-heart surgery through 1-2 cm incisions. Learn More. 160; 8.92. Minimum 20 minute delay.